Tag: Allergan

Allergan is a multi-national pharmaceutical that produces branded and generic drugs, and performs pharmaceutical research and development. Formerly known as Actavis.

Allergan to Establish R&D presence in US

The new, strategic presence will allow the company to more easily interact and engage with venture firms and start ups in the area. Allergan will establish an R&D presence in the Kendall Square...

Allergan Suspended Sales of Breast Imlants in Europe

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that the company has suspended sales of textured breast implants and tissue expanders and is withdrawing any remai...

Big Pharma Companies to Raise Drug Prices in January

Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry...

Allergan and Sosei breaked trials of Alzheimer’s drug

Sosei (Japan) and Allergan (USA) have been forced to call a halt to testing of a drug for Alzheimer’s disease and other forms of dementia after cancer was seen in non-human primate studies. The dru...

Allergan acquires neurotoxin biotech Bonti

Allergan announced it has agreed to acquire Bonti, a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs.

Allergan and Editas Medicine keep up their work on CRISPR genome editing drug

Allergan and Editas Medicine announced that Allergan's wholly-owned subsidiary has exercised its option to develop and commercialize EDIT-101 globally for the treatment of LCA10.

Biosimilar ABP 980 obtained a positive opinion from CHMP

cancer treatment
Amgen and Allergan have announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the marketing authorisation of ABP 980, a biosimilar to Herceptin®.

Teva will receive $700 million from Allergan

Allergan PLC, headquartered in Dublin, Ireland, a global pharmaceutical company, will pay Teva Pharmaceutical Industries Ltd. $700 million to dismiss a dispute between the two companies

Allergan will buy Zeltiq Aesthetics for $2.48 billion

Botox maker Allergan agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic produ...